Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Disease area: Interstitial lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vial-Dupuy, O. Sanchez, K. Juvin, D. Israël-Biet (Paris, France). Outcome of acute drug-induced pneumonias in ICU. Eur Respir J 2013; 42: Suppl. 57, 2362

Member's Comments

No comment yet.

Related content which might interest you: Methotrexate reduces acute lung injury in a murine model of sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Markers of poor outcome in patients with acute hypoxemic respiratory failure Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Homooligomerization of the ABC-transporter 3 and its functional significance Source: International Congress 2014 – ILDs 3 Year: 2014 Lung recruitment maneuver with and without nebulized albuterol for acute lung injury Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014 Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014 Dysfunction of oxidized pulmonary surfactant is cholesterol-dependent Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Essential oils reduced lung inflammation in a model of acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Radiologic features of lung involvement in young patients with viral pneumonia Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Effects of nebulized heparin in a rat-model of endotoxemia-induced lung injury Source: International Congress 2014 – Critical illness and therapeutic interventions Year: 2014 Helmet ventilation in AIDS patients with severe pneumonia and acute hypoxaemic respiratory failure Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications Year: 2013 Survival in IPF acute exacerbations: The non-steroid approach Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Septic pulmonary embolisms as a cause of acute respiratory distress syndrome Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Expression of water and ion channels proteins in acute respiratory distress syndrome from different etiologies Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI) Source: International Congress 2014 – ILDs 6 Year: 2014 Clinical and microbiological characteristics and outcome of ARDS in India Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Morbi-mortality evaluation in prolonged prone positioning during severe ARDS Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Drug-associated acute respiratory distress syndrome: A prospective observational cohort study Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Assessing regional PEEP-related airway opening and dilatation in ARDS patients Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage Year: 2015 Lung protective ventilator settings for lung transplantation? The Harefield experience Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013